244
The Russian Fund for Direct Investments (Rdif) has reached an agreement with Stelis Biopharma for the production in India of 200 million doses of the Russian Sputnik V vaccine against Covid-19: the news agency Ria Novosti reports, quoting the same Rdif.
“The Russian Fund for Direct Investments and Stelis Biopharma announce a partnership for the production and supply of at least 200 million doses of the Russian vaccine against covid Sputnik V which will allow the vaccination of 100 million people” reads the statement taken from Ria Novosti.